25 September 2020 | News
The team aims to use this funding for product approvals, sales, and marketing
Chiratae Ventures, India’s leading Venture Capital fund have announced their seed investment in WeInnovate Biosolutions, a Pune based startup working in the area of Infection prevention and control as a part of their DeepTech Innovators Program 6th Cohort.
The company has developed antimicrobial solutions that reduce hospital-acquired infections and is helping save millions on hospitalization bills. The funding from this round will be used for product approvals, sales, and marketing.
This DeepTech Innovators program by Chiratae Ventures is the 6th edition consolidating all the previous programs for the seed and early-stage start-ups with a focus on solving real, major problems through deep-technology across sectors. Over 250+ companies were part of this program across horizontal tech, mobility, robotics, energy, aerospace, biotech, life sciences, etc. This initiative is in-line with Chiratae’s continued effort to back deep technology solutions and boost innovative thinking coming out of India.
Founded in 2016 by three friends, Dr. Milind Choudhari, Dr. Prasad Bhagat & Dr. Anupama Engineer, Weinnovate Biosolutions is on a mission of ‘Zero Infections’ during a hospital stay. The company aims to achieve this through its range of antimicrobial medical devices that are based on the company’s patented unique, cutting-edge NanoAgCide technology. Their team consists of dedicated scientists and technologists, working together in developing solutions that are rapid and affordable. Their mentors include medical doctors, business strategists, pre-clinical and clinical studies advisors, and product building experts.